Pharmaron Beijing Co., Ltd. (SHE:300759)

China flag China · Delayed Price · Currency is CNY
29.21
+0.18 (0.62%)
At close: Dec 5, 2025
6.57%
Market Cap 48.92B
Revenue (ttm) 13.54B
Net Income (ttm) 1.51B
Shares Out 1.77B
EPS (ttm) 0.86
PE Ratio 34.12
Forward PE 23.56
Dividend 0.20 (0.69%)
Ex-Dividend Date Jul 4, 2025
Volume 10,689,830
Average Volume 15,081,823
Open 28.94
Previous Close 29.03
Day's Range 28.67 - 29.21
52-Week Range 20.47 - 37.63
Beta 1.16
RSI 42.31
Earnings Date Mar 26, 2026

About Pharmaron Beijing

Pharmaron Beijing Co., Ltd., together with its subsidiaries, operates as a pharmaceutical research and development service platform in North America, Europe, the Mainland China, Asia, and internationally. It operates through five segments: Laboratory Services; Chemical and Formulation Process Development and Production Services; Clinical Research Services; Macromolecule and Cell and Gene Therapy Services; and Others. The company offers laboratory chemistry and biological science services, including small molecule chemical drugs, oligonucleotide... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2004
Employees 21,370
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300759
Full Company Profile

Financial Performance

In 2024, Pharmaron Beijing's revenue was 12.28 billion, an increase of 6.39% compared to the previous year's 11.54 billion. Earnings were 1.79 billion, an increase of 12.01%.

Financial Statements

News

There is no news available yet.